Literature DB >> 3659583

Antitussive effect of dextromethorphan and dextromethorphan-salbutamol combination in healthy volunteers with artificially induced cough.

P Karttunen1, H Tukiainen, M Silvasti, S Kolonen.   

Abstract

The antitussive effects of dextromethorphan (30 mg) + salbutamol (2 mg), dextromethorphan (30 mg) alone and placebo on artificial cough induced by citric acid were compared in 19 healthy non-smoking volunteers in a double-blind crossover study. The method using inhaled citric acid with increasing concentrations to establish the cough threshold level showed an acceptable reproducibility and proved to be suitable for comparison of antitussive drugs. The cough threshold level was assessed before as well as 90 and 180 min after each medication. After placebo the cough threshold level showed no statistically significant rise. However, significant rises were shown following dextromethorphan (p less than 0.001) and the dextromethorphan-salbutamol combination (p less than 0.001). Between the treatments significant differences were shown in favour of the dextromethorphan-salbutamol combination. The results indicate that salbutamol has antitussive action enhancing the effect of plain dextromethorphan.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3659583     DOI: 10.1159/000195303

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  6 in total

Review 1.  Cough: an unmet clinical need.

Authors:  Peter V Dicpinigaitis
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

2.  The antitussive effect of dextromethorphan in relation to CYP2D6 activity.

Authors:  R Abdul Manap; C E Wright; A Gregory; A Rostami-Hodjegan; S T Meller; G R Kelm; M S Lennard; G T Tucker; A H Morice
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

3.  Physiologically based modelling of inhibition of metabolism and assessment of the relative potency of drug and metabolite: dextromethorphan vs. dextrorphan using quinidine inhibition.

Authors:  A A Moghadamnia; A Rostami-Hodjegan; R Abdul-Manap; C E Wright; A H Morice; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

4.  Assessment of antitussive efficacy of dextromethorphan in smoking related cough: objective vs. subjective measures.

Authors:  James Ramsay; Caroline Wright; Rachel Thompson; David Hull; Alyn H Morice
Journal:  Br J Clin Pharmacol       Date:  2008-02-15       Impact factor: 4.335

Review 5.  Dextromethorphan. An overview of safety issues.

Authors:  J L Bem; R Peck
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

Review 6.  Peripheral mechanisms II: the pharmacology of peripherally active antitussive drugs.

Authors:  D Spina; I McFadzean; F K R Bertram; C P Page
Journal:  Handb Exp Pharmacol       Date:  2009
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.